Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Immunomedics Company Profile (NASDAQ:IMMU)

Consensus Ratings for Immunomedics (NASDAQ:IMMU) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $6.33 (73.99% upside)

Analysts' Ratings History for Immunomedics (NASDAQ:IMMU)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/30/2014Panmure GordonReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2014R. F. LaffertyDowngradeBuy -> Neutral$4.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014Chardan CapitalInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
10/2/2013OppenheimerBoost Price TargetOutperform$6.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
9/10/2013R. F. LaffertyInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
6/3/2013WallachBeth CapitalInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/22/2012 forward)
Discuss Immunomedics